122 related articles for article (PubMed ID: 15931713)
1. NME digest.
Drug News Perspect; 2005 Apr; 18(3):190-6. PubMed ID: 15931713
[No Abstract] [Full Text] [Related]
2. [Amidinohydrazones as subjects of drug research. 2].
Richter PH; Wunderlich I; Schleuder H; Keckeis A
Pharmazie; 1993 Mar; 48(3):163-84. PubMed ID: 8493282
[No Abstract] [Full Text] [Related]
3. NME digest.
Drug News Perspect; 2003; 16(1):41-7. PubMed ID: 12739555
[No Abstract] [Full Text] [Related]
4. QSAR study on dual 5-HT1A and 5-HT1B antagonists: an insight into the structural requirement for antidepressant activity.
Dessalew N
Arch Pharm (Weinheim); 2008 May; 341(5):314-22. PubMed ID: 18389517
[TBL] [Abstract][Full Text] [Related]
5. New drugs of 1992.
Hussar DA
Am Pharm; 1993 Apr; NS33(4):20-56. PubMed ID: 8475853
[No Abstract] [Full Text] [Related]
6. DNA and RNA synthesis: antifolates.
Kompis IM; Islam K; Then RL
Chem Rev; 2005 Feb; 105(2):593-620. PubMed ID: 15700958
[No Abstract] [Full Text] [Related]
7. New drugs of 1989.
Hussar DA
Am Pharm; 1990 Mar; NS30(3):27-49. PubMed ID: 2316446
[No Abstract] [Full Text] [Related]
8. Sulfonamides with the N-alkyl-N'-dialkylguanidine moiety as 5-HT7 receptor ligands.
Zajdel P; Subra G; Verdie P; Gabzdyl E; Bojarski AJ; Duszyńska B; Martinez J; Pawłowski M
Bioorg Med Chem Lett; 2009 Aug; 19(16):4827-31. PubMed ID: 19560916
[TBL] [Abstract][Full Text] [Related]
9. WAY 405, a new silent 5-HT (1A) receptor antagonist with low affinity for vascular alpha (1)-adrenoceptors.
Villalobos-Molina R; Orozco-Méndez M; López-Guerrero JJ; Gallardo-Ortíz IA
Auton Autacoid Pharmacol; 2005 Oct; 25(4):185-9. PubMed ID: 16176451
[TBL] [Abstract][Full Text] [Related]
10. Synthesis of new serotonin 5-HT7 receptor ligands. Determinants of 5-HT7/5-HT1A receptor selectivity.
Medina RA; Sallander J; Benhamú B; Porras E; Campillo M; Pardo L; López-Rodríguez ML
J Med Chem; 2009 Apr; 52(8):2384-92. PubMed ID: 19326916
[TBL] [Abstract][Full Text] [Related]
11. 5-HT1A and 5-HT1B receptor agonists and aggression: a pharmacological challenge of the serotonin deficiency hypothesis.
de Boer SF; Koolhaas JM
Eur J Pharmacol; 2005 Dec; 526(1-3):125-39. PubMed ID: 16310183
[TBL] [Abstract][Full Text] [Related]
12. Fluorine in pharmaceutical industry: fluorine-containing drugs introduced to the market in the last decade (2001-2011).
Wang J; Sánchez-Roselló M; Aceña JL; del Pozo C; Sorochinsky AE; Fustero S; Soloshonok VA; Liu H
Chem Rev; 2014 Feb; 114(4):2432-506. PubMed ID: 24299176
[No Abstract] [Full Text] [Related]
13. [Development of new drugs in Nippon (author's transl)].
Kobo B
Pharmazie; 1981 Dec; 36(12):799-804. PubMed ID: 7330081
[No Abstract] [Full Text] [Related]
14. The effects of drugs on wound healing--part II. Specific classes of drugs and their effect on healing wounds.
Karukonda SR; Flynn TC; Boh EE; McBurney EI; Russo GG; Millikan LE
Int J Dermatol; 2000 May; 39(5):321-33. PubMed ID: 10849120
[No Abstract] [Full Text] [Related]
15. Development of 5-HT1A receptor radioligands to determine receptor density and changes in endogenous 5-HT.
Jagoda EM; Lang L; Tokugawa J; Simmons A; Ma Y; Contoreggi C; Kiesewetter D; Eckelman WC
Synapse; 2006 May; 59(6):330-41. PubMed ID: 16440292
[TBL] [Abstract][Full Text] [Related]
16. Synthesis and 5-HT(1A), 5-HT(2A) receptor activity of new beta-tetralonohydantoins.
Byrtus H; Pawłowski M; Czopek A; Bojarski AJ; Duszyńska B; Nowak G; Kłodzińska A; Tatarczyńska E; Wesołowska A; Chojnacka-Wójcik E
Eur J Med Chem; 2005 Aug; 40(8):820-9. PubMed ID: 16122584
[TBL] [Abstract][Full Text] [Related]
17. In vitro profile of the antidepressant candidate OPC-14523 at rat and human 5-HT1A receptors.
Jordan S; Chen R; Koprivica V; Hamilton R; Whitehead RE; Tottori K; Kikuchi T
Eur J Pharmacol; 2005 Jul; 517(3):165-73. PubMed ID: 15985260
[TBL] [Abstract][Full Text] [Related]
18. [Significance of initial emotional state for neuroimmunomodulation under conditions of activation or blockade of 5-HT1A receptors].
Idova GV; Davydova SM; Cheĭdo MA; Zhukova EN; Devoĭno LV
Zh Vyssh Nerv Deiat Im I P Pavlova; 2005; 55(4):567-72. PubMed ID: 16217972
[TBL] [Abstract][Full Text] [Related]
19. 5-HT1A receptor-mediated G protein activation assessed by [35S]GTPgammaS binding in rat cerebral cortex.
Odagaki Y; Toyoshima R
Eur J Pharmacol; 2005 Oct; 521(1-3):49-58. PubMed ID: 16182280
[TBL] [Abstract][Full Text] [Related]
20. Metabolism-based drug interactions involving oral azole antifungals in humans.
Strolin Benedetti M; Bani M
Drug Metab Rev; 1999 Aug; 31(3):665-717. PubMed ID: 10461546
[No Abstract] [Full Text] [Related]
[Next] [New Search]
